Suspected local disease regrowth was seen in 23% of patients with rectal cancer observed following a near or complete clinical response to neoadjuvant therapy.
Two approaches to downstaging muscle-invasive bladder cancer prior to radical cystectomy include neoadjuvant chemotherapy and transurethral resection.
ERAS clinical pathways typically involve early ambulation, and the early introduction of liquid and solid diets following surgery.
Synchronous metastatic disease is characterized by the presence of metastatic lesions, in addition to the primary tumor, at diagnosis.
The odds of postoperative complications were lower at top-ranked hospitals compared with non–top-ranked hospitals across a specific subset of cancer types.
Addition of surgery prior to chemotherapy does not prolong overall survival in recurrent ovarian cancer.
A retrospective chart review conducted after implementing an ERAS program demonstrated that improved patient education led to less use of opioids in the immediate postoperative period.
Hazard ratio 0.44 for incident cancer with loss of at least 20 to 35 versus <20 percent of total body weight.
For individuals with obesity, risk for skin cancer and melanoma significantly reduced with bariatric surgery.
Traditionally, approaches to the management of patients with nonmetastatic CRPC following radical prostatectomy have been limited.
